Search

Date 2022 Author/Creator Van Solingen-Ristea, Rodica

1. Brief Report: Evaluation of Inflammation and Atherogenesis Biomarkers Through 148 Weeks Postswitch to Dolutegravir and Rilpivirine in SWORD-1/SWORD-2. (1st September 2022)

Authors:
Llibre, Josep M.; López Cortés, Luis Fernando; Aylott, Alicia; Wynne, Brian; Matthews, Jessica; Van Solingen-Ristea, Rodica; Vandermeulen, Kati; van Wyk, Jean; Kahl, Lesley P.
Journal:
Journal of acquired immune deficiency syndromes
Issue:
Volume 91:Number 1(2022)
Page Start:
73
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment. (1st February 2022)

Authors:
Swindells, Susan; Lutz, Thomas; Van Zyl, Lelanie; Porteiro, Norma; Stoll, Matthias; Mitha, Essack; Shon, Alyssa; Benn, Paul; Huang, Jenny O.; Harrington, Conn M.; Hove, Kai; Ford, Susan L.; Talarico, Christine L.; Chounta, Vasiliki; Crauwels, Herta; Van Solingen-Ristea, Rodica; Vanveggel, Simon; ...
Journal:
AIDS
Issue:
Volume 36:Number 2(2022)
Page Start:
185
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment. (1st February 2022)

Authors:
Swindells, Susan; Lutz, Thomas; Van Zyl, Lelanie; Porteiro, Norma; Stoll, Matthias; Mitha, Essack; Shon, Alyssa; Benn, Paul; Huang, Jenny O.; Harrington, Conn M.; Hove, Kai; Ford, Susan L.; Talarico, Christine L.; Chounta, Vasiliki; Crauwels, Herta; Van Solingen-Ristea, Rodica; Vanveggel, Simon; ...
Journal:
AIDS
Issue:
Volume 36:Number 2(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search